BEAT BioTherapeutics Corp.
Bellevue, WA 98004
Research Sector Biotechnology
Summary Description Therapies for heart disease, based on a fundamental discovery in cardiac muscle contractionManagement Michael Kranda, CEO; Gregory G, Mahairas, Ph.D.
Click here for Financial Data
Keywords: Heart Disease, Cardiac Failure, Gene Therapy, heart, cardiology, cardio, datp
Updated: Dec. 08, 2015
BEAT BioTherapeutics Corp. (BEATBio) is a biotechnology company founded to develop novel therapies for heart disease. BEAT Bios first product is based on a fundamental discovery in cardiac muscle co......view more
Technology / Differentiation
The founders discovery employs a novel biological agent for therapeutic use by raising the production of DeoxyAdenosine Triphosphate (dATP) in the metabolic synthesis of ATP. Essentially, the hearts...view more
Market / Customers
26 million people worldwide survive after suffering from heart failure. The market for heart disease therapeutics was $3 B in 2005 and grew at a Compound Annual Growth Rate of 4.5% to reach $4.1 B in ......view more
Revenue / Funding
Funding to date - $3M; Financing sought Series A preferred equity, up to $18M...view more
Cooley LLP...view more